chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe nausea and vomiting from 8:30 am to 3:30 pm.  Vomited every 5-10 minutes  Severe body aches/chills the entire time  Violently vomiting - dry heaves (started right when I woke up so empty stomach from the start) Could not keep even a sip of water down for over 7 hours.  If I were not in a rural area I would have sought Urgent care.  Just could not spend 45 min- 1hour in a vehicle while so violently ill. I have a doctor appointment on 4/14 to discuss with doc
I received my booster shot after being eligible and about an hour later  started feeling a weird feeling in my mouth. I developed blisters all over my mouth and tongue. Throat is hurting, major headache and extreme discomfort to the extend I can?t eat. Doctor prescribed some meds which are not working.
got the vaccine last year and tested positive; got the vaccine last year and tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got the vaccine last year and tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: tested positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The caller claims that she experienced COVID symptoms a year ago. She had received all of her Pfizer COVID-19 shots by that time. The patient was prescribed Paxlovid and fine after that. Caller would like to know if the vaccine is still effective.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
The pt experienced a large amount of swelling to the thigh beginning 36 hours post vax and lasting 3 days which was approximately the size of an orange and 3/4 around the thigh and was very red and hot to the touch. The child was fussy and did not feel good. Temp is normal. Treated with Tylenol every 4 hours.
Patient inadvertently received vaccine after expiration date. Moderna  Company analyzed lot 007B21A  and advised this lot  maintained the activity necessary to protect  against covid 19 at time of administration. . Patient did not call in to report any adverse event. This is an administrative error without adverse event.
Given Anthrax vaccine #4 (lot# FAV069) on 9-6-03 noticed subtle physical change - joint pain, fatigue, head-aches & a large varicose vein on my lower left leg.  In June 2007 I had 3 blood clots in same leg & was diagnosed w/ autoimmune disease - antiphospholipid syndrome - non-curable.  Taking Coumadin daily for rest of my life.  06/23/2008 MR received dated 9/04/2007-1/09/2008 with DX: Antiphospholipid antibody syndrome manifested with DVT of the LLE in conjuntion with a prolonged APTT and dilute Russell viper venom time of significant inhibition on a 1:1 mix; presence of lupus anticoagulant, presence of phospholipid IgG antibody, and presence of beta 2 GPI antibody IgGs.  In addition, the beta 2 GPI antibody IgA was borderline. DVT. Migraine Headaches.
Acute midsternal chest pain and dyspnea, within 24hours of injection 11/18/21, she presented to the ED the following day, EKG, labs and cardiac enzymes normal, she started on NSAIDs (ibuprofen), fluids and rest, symptoms did not improve. I saw her in my clinic 11/22/21 her symptoms were persistent, her EKG remained unremarkable, I sent her for repeat labs and echocardiogram, she has mildly elevated high sensitivity CRP and small pericardial effusion w/o evidence of tamponade. I have started her on medical therapy for pericarditis of continued NSAIDs and Colchicine as well as exercise restriction, she will follow up with  me in my clinic
sickest; positive for covid; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On 24th September 2021, unknown after receiving Shingles vaccine, the patient experienced covid-19. On an unknown date, the patient experienced sickness. On an unknown date, the outcome of the sickness and covid-19 were unknown.   It was unknown if the reporter considered the sickness and covid-19 to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The patient one Shingles shot and got very sick. On the day of reporting, the patient was positive for Covid. The follow-up would not possible as no contact details were available. This case was linked with the case US2021AMR202764 and US2021AMR202898, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR202764:same reporter US-GLAXOSMITHKLINE-US2021AMR202898:same reporter
Information has been received from a medical assistant referring to a 15 months old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 12-JUN-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # K021151 with expiration date 02-NOV-2016; dose and route of administration were not reported). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
The same night after the vaccine I had shaking violent chills, my teeth were chattering as well. I also was vomiting a lot , I had lots of chills that I could not get warm this went on all night long. The next day I did experience some bad body aches like the flu. The next day after that I slept all day long and tried to hydrate myself back together. Over the next few weeks I noticed how I was running out of breath so fast. I am now suffering from shortness of breath.
This literature marketed report was received from the authors in a published literature abstract title as stated below, concerning a 66 year old female patient (typed B*39:01, 44:02). The aim of this study was to analyze the reasons of fast (10 days) development of strong DSA in the recipient after single lung transplantation. The patient had two children. (typed 8*07:02, 44:02) and 1983 (typed 8*27:03, 39:01). The patient received pneumococcal (P) (manufacturer unknown) and shingle vaccinations zoster vaccine live (manufacturer unknown) in August 2008 and September 2009, respectively. In October 2014 the patient received pneumococcal (P) (manufacturer unknown) vaccination followed by two hepatitis a hepatitis a virus vaccine (manufacturer unknown) and hepatitis b virus vaccine (in September 2015 and in October 2015), diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (manufacturer unknown) in September 2015, influenza virus vaccine  and M-M-R II (dose, route, lot# and the expiration date were not reported)for prophylaxis in October 2015. There was no concomitant medication provided. It was reported that hepatitis a hepatitis a virus vaccine (manufacturer unknown), zoster vaccine live (manufacturer unknown) and M-M-R II vaccines contain viruses grown on live human lung fibroblasts (HLF) (MRC-5, typed 8*07:02, 44:02, and WI-38, typed 8*08:01, 58:01). Each dose of vaccine used for injection was known to contain protein components of hepatic leukemia factor (HLF) including Human leukocyte antigen (HLA). On 07-FEB-2016, the patient underwent single lung transplant (typed 8*81:01,15:17)  with negative Donor specific antibodies (DSA) and flow cytometry cross match (FC XM).Historical samples did not have any DSA and were FC XM negative. On 17-FEB-2016, a strong donor specific antibodies to B81 were detected in the patient. At the time of reporting, the outcome of donor specific antibody present was unknown.  Conclusions: Most likely fast de novo DSA development was due to immunological memory booster effect produced by five exposures to MM B locus alleles which share the following Es: 70IAQ. 65QIA, 65QIA+76esn, 69aa+80n, and 163ew+73te. The later three consist of paired non-self and self Es. Additional information has been requested.
Low grade fever and severe body aches as well as headache that  started within 24 hours of shot and lasted approximately 24 hours later.
Raised red patch on inner left hand palm, approximately half inch by three-quarters of an inch Increased in redness after second Moderna vaccine (Lot 045A21A) on 4/3/21. Still there. Not painful, just itchy. Dermatologist diagnosed it on 4/19/21 as vasculitis following  Moderna vaccine. Rite Aid location has closed pharmacy since 2nd vaccine shot
High Fever, bellyache, tired with MOTRIN temp came down, bellyache resolved
Swelling, redness, pain/tenderness Red ring rash that was itchy for a few days, subsided, then returned a week after the injection
Swollen lymph node under left arm the size of kiwi. Notice 12/22 in the evening.  No improvement with warm compress.
31 year old female with no know allergies. Approximately 19 minutes after receiving 1st dose of pfizer COVID vaccine exited the observation area and went to restroom, additional staff notice client over toilet with c/o nausea and sweating. Staff alerted Nursing staff, Client taken back to observation area with 3 Nursing staff member, client sweating profusely, vitals assessed, b/p-126/92p-88 spo2-99%t-98.0 . Water and Salty snack given, client monitored for additional 30 mins, vitals stable, no c/o nausea or vomiting, sweating subsided
pt devel chickenpox w/high fever 4 days p/vax;parents believe the vaccine gave pt the illness
flu aped frozen shoulder; more than likely the person who gave you the shot gave it way too high; Initial information was received on 28-Sep-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves an adult patient (gender not reported) had flu aped frozen shoulder (periarthritis) after receiving vaccine INFLUENZA VACCINE and more than likely the person who gave the shot gave it way too high (product administered at inappropriate site).  The patient had no medical history, concomitant disease or risk factor.  Past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  It was case of actual medication error due to vaccine administered at inappropriate site (latency: same day).  It was reported "so more than likely the person who gave you the shot gave it way too high. That was one of the first things that were taught when administering vaccines. This happened to a friend of mine"  On an unknown date, the patient developed a non-serious flu aped frozen shoulder (periarthritis) (unknown latency) following the administration of INFLUENZA VACCINE. This lasted two years.  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome of the event was unknown.  There would be no information available on batch number for this case.
patient noticed numbness in both arms on 10/15 by night time had a headache on 10/16 could not walk was numb all over. currently hospitalized in hospital.
Received the Moderna COVID-19 Vaccine EUA on 01/21/2021 @ 10:30am in my left arm.  On 01/25/2021 in the evening I noticed a soreness in my left collarbone and  felt what I think is a swollen gland.  I have not pursued any additional medical assistance from my primary care physician or my healthcare specialist.
The day after I received the vaccine, I had a sore arm, dizziness, chills, heart palpations, extreme fatigue, stiff neck, tingling and creepy-crawly feelings in my torso, arms, up my neck, into my head, and thighs . The dizziness was so intense, I was unable to drive, or even walk without hanging on to something. I slept most of the day. These symptoms have continued for 21 days.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 64-year-old male patient who received SHINGRIX (batch number Z9RR4, expiry date 15th November 2020) for prophylaxis. On 12th June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were reported as follows: The health care professional (HCP) reported that after receiving a dose of SHINGRIX, the patient developed a mild case of shingles prior to receipt of the second dose of SHINGRIX.
flu like symptoms; achy; dizzy; headache; Naucous; tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), INFLUENZA LIKE ILLNESS (flu like symptoms), HEADACHE (headache), NAUSEA (Naucous) and PAIN (achy) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included AFib.    On 04-Jun-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 04-Jun-2023, the patient experienced DIZZINESS (dizzy), INFLUENZA LIKE ILLNESS (flu like symptoms), HEADACHE (headache), NAUSEA (Naucous), PAIN (achy) and FATIGUE (tired). At the time of the report, DIZZINESS (dizzy), INFLUENZA LIKE ILLNESS (flu like symptoms), HEADACHE (headache), NAUSEA (Naucous), PAIN (achy) and FATIGUE (tired) was resolving.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was reported. It was unknown if the patient experienced any additional symptoms/events.  The patient was suggested with bed rest until could go back to work.  It was unknown if the patient had any additional medical history, concomitant disease or risk factor. No treatment medication information was reported.
Rash on arms after contact with the skin. Tingling/numbing sensation on the tip of the tongue. Reaction during vaccine administration/preparing not receiving.
The next day, I had a sore arm and didn't feel well. Day 2-5 I did have some bowel issues. I had diarrhea, nausea and headache. My headache affected my forehead and the back of my neck. I never had a fever. Like my adverse event of my first dose of the COVID vaccine I started to have my oxygen drop and not coming back up. Five days after my vaccination I had to call 911 and was taken to the ER and they admitted me into the hospital for 3 days. They kept me on oxygen and prednisone. That seemed to help. The released me after 3 days. because I was stable.
This spontaneous report as received from a medical assistant refers to a 16 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 27-JUN-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
Diarrhea came two days after for four days.; Sore arm.; Head felt numb-ish; tingly on right side and sore shoulder/arm; tingly on right side and sore shoulder/arm; small bumps on head and headache/Bumps moving and forming in different areas side of vaccine; headache; Then, five days or later large bumps formed on head. Top of head, then moved to right side of head, lymph nodes and right side of neck swelling; Then, five days or later large bumps formed on head. Top of head, then moved to right side of head, lymph nodes and right side of neck swelling; Then, five days or later large bumps formed on head. Top of head, then moved to right side of head, lymph nodes and right side of neck swelling; Face swelling; Throat swelling; This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER8734), via an unspecified route of administration, administered in Arm Right on 10Apr2021 14:00 (at the age of 46-year-old) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications. Patient did not have any known allergies. Patient did not receive any other vaccine in four weeks and did not receive any other medications in two weeks. Patient did not have covid prior vaccination and covid was not tested post vaccination. Patient reported that Diarrhea came two days after (on 12Apr2021) for four days. Sore arm, Head felt numb-ish, tingly on right side and sore shoulder/arm. Then, small bumps on head and headache. Then, five days or later large bumps formed on head, top of head, then moved to right side of head, lymph nodes and right side of neck swelling. Very severe headache 7 days later. Emergency call was made to doctor and doctor was visited. Bumps moving and forming in different areas side of vaccine. Also experienced face swelling, throat swelling all on right side. Adverse events started on 10Apr2021 18:00. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment as Benadryl, Tylenol and Advil so far. The outcome of diarrhea was recovered on 16Ap2021 and for all other events was not recovered.   No follow-up attempts are possible. No further information is expected.
Patient received vaccine at approximately 9:50am, reaction started around 10:20 am while pt was teaching, coverage for class arrived and pt went to clinic at 11:05, but nurses were gone. Pt sent to ER due to tingling in (R) hand/arm, redness in both arms, swelling to face, eyes, given Prednisone in ER and a Rx for prednisone and an EPIPEN.
Patient complaint of itching over entire body, started within 2 min of administration. Benadryl 25mg/IM right deltoid. Condition resolved 30 minutes of Benadryl Injection.
This prospective pregnancy case was reported in a literature article and described the occurrence of preterm labor in a female subject who received Flu Seasonal QIV Dresden. On an unknown date, less than a year after receiving Flu Seasonal QIV Dresden, the subject developed preterm labor. Serious criteria included other: serious per reporter. Additional event(s) included vaccine exposure during pregnancy. The outcome of preterm labor was unknown. The outcome(s) of the additional event(s) included vaccine exposure during pregnancy (unknown). The pregnancy was lost to follow up. The investigator considered that there was a reasonable possibility that the preterm labor may have been caused by Flu Seasonal QIV Dresden. Additional information was provided This prospective pregnancy case was reported in this literature article and described the occurrence of preterm labour in a female aged above 10-years who was vaccinated with seasonal inactivated influenza vaccine (manufacturer unknown) during pregnancy. The patient was part of a study that assessed the safety of seasonal inactivated influenza vaccines (IIV) and live attenuated influenza vaccines (LAIVs) in pregnant women and their infants whose reports were submitted to Vaccine Adverse Event Reporting System (VAERS) during 2010-2016. No information on patient's medical or family history or concurrent condition or concomitant medication was provided. On an unspecified date, the patient received unspecified seasonal inactivated influenza vaccine (administration route and site unspecified; dosages unknown; batch number not provided) during pregnancy. On an unspecified date between 1 July 2010 and 6 May 2016, an unknown period after vaccination during pregnancy, the patient experienced preterm labour. This case has been considered as serious as per the authors. Treatment was unknown. The outcome of the event was not reported. The authors did not comment on the relationship between preterm labour and unspecified seasonal inactivated influenza vaccine. However the authors stated, "VAERS also generally cannot determine whether a vaccine caused an AE." The authors concluded that "During the study period 2010-2016, the average annual number of VAERS reports following IIV in pregnancy decreased compared with the 2009-2010 pandemic period but remained higher than prior to the pandemic. Similar to the 2009-2010 period, no new or unexpected patterns in maternal or fetal outcomes were observed during 2010-2016. Maternal influenza vaccination benefits both the mother and the infant, protecting both from influenza disease. Given that the antigenic composition of these vaccines usually changes each season, the CDC and FDA will continue to monitor the safety of influenza vaccines in pregnant women." This is 1 of the 12 valid cases reported in the same literature article.
Had the shots, now have shingles/suspected vaccination failure; shingles/had shots but now have shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 29-Jul-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the shots but now have had shingles. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Rash of itchy raised bumps all over face, neck, back of head, upper back and upper chest.
Patient had redness and soreness at injection site that lead to infection and patient needing to take antibiotic.
30 min after vaccine she became hot, flush, dizzy, heart pounding, hands face and feet were numb and tingly, she passed out at her desk and was taking to the ER for evaluation. Benadryl & Solumedrol Admin with hydration with NS.   Pt discharged from ER.  Pt in ~10am discharged from ER ~2hrs later.
Pt states she experienced local soreness and swelling as well as some nausea and maybe some fever after receiving flu shot and pneumonia shot. Pt was referred to PCP.